A
PSIL
AdvisorShares Psychedelics ETF
20.16
+0.41+2.08%After Hours: 20.01 -0.15 -0.74%17:10 06/12 EDT
OPEN/PREV CLOSE19.85/19.75
TODAY RANGE19.55-20.28
VOL13.76K
TOTAL ASSET33.63M
52 WEEK RANGE12.17-22.49
% TURNOVER0%
NAV19.79
EXPENSE RATIO(NET)1.00%
1Y RETURN(CUM.)53.86%
DIVIDEND1.879
DIV YIELD9.32%
EX-DATE12/22/2025
% RANGE3.52%
INCEPTION DATE09/15/2021
BETA--
LOT SIZE1
LIPPER RATING-
News
TipRanks·04/29 18:08
Beyond Cannabis: 3 Stock Picks Tied to the Psychedelics Trade
TipRanks·04/24 16:22
3 Different Ways to Play the Rally in Psychedelic Stocks
Seeking Alpha·04/20 11:31
Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research
Benzinga·03/16 17:35
NRx Pharma Stock Jumps After FDA Signals Path To NDA For Ketamine Depression Drug
Benzinga·02/17 14:12
COMPASS Pathways Triumph In Hard To Treat Depression Ignites Investor Frenzy
Seeking Alpha·01/22 12:15
2025 ETF Wrap-Up And What To Expect In 2026
NASDAQ·12/31/2025 16:00
Best-Performing Active ETFs of 2025
Seeking Alpha·09/22/2025 10:13
AdvisorShares Psychedelics ETF declares quarterly distribution of $0.0200
Benzinga·08/05/2025 18:25
Quantum Biopharma Reports Positive Phase 1 Safety For Multiple Sclerosis Drug
NASDAQ·06/20/2025 14:00
5 ETFs That Beat the Market in the First Half of 2025
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others